Astrum CEO Elisabeth Lackner attended the CPHI Milan meeting.

At Astrum, we offer a full range of clinical development services spanning the entire drug development life cycle. Our client-focused approach coupled with our size means we can deliver end-to-end services or stand-alone solutions that are fully tailored to our client’s needs. Our ability to adapt to the specific requirements of each project, maintaining focus on every detail, while always keeping sight of the bigger picture, ensures that we provide optimal solutions for our clients.